Skip to search form
Skip to main content
Semantic Scholar's Logo
Create Free Account
You are currently offline. Some features of the site may not work correctly.
, Rifamycin, 3-(methyl(1-piperidinylmethylene)hydrazino)-
National Institutes of Health
Semantic Scholar uses AI to extract papers important to this topic.
[Chemotherapeutic agents under study].
Nihon rinsho. Japanese journal of clinical…
Corpus ID: 26549278
The development of new drugs with strong antituberculous activity and fewer side effects which are not cross-resistant to…
[Disposition of 3-(N-piperidinomethylarino)methyl-rifamycin SV (FCE 22250) in rats].
Zhongguo yao li xue bao = Acta pharmacologica…
Corpus ID: 41067716
After rats being given ig FCE 22250 5, 10 and 25 mg.kg-1, the plasma peak times (Tmax) were 12-14 h, the max plasma…
In vitro observations on the suitability of new rifamycins for the intermittent chemotherapy of tuberculosis.
Corpus ID: 13312996
The bactericidal activity of six new rifamycin derivatives--rifabutin (RBU), FCE 22250 (F22), rifapentine (RPE), CGP 29861 (C29…
Laboratory evaluation of a new long-acting 3-azinomethylrifamycin FCE 22250.
C. Della Bruna
The Journal of antibiotics
Corpus ID: 12218329
FCE 22250 (3-(N-piperidinomethylazino)methylrifamycin SV) is a member of the new class of 3-azinomethylrifamycins characterized…
Physico-chemical properties of FCE 22250, 3-(piperidinomethylazinomethyl)rifamycin SV, a new long-acting rifamycin.
Il Farmaco; edizione pratica
Corpus ID: 9960729
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Terms of Service
ACCEPT & CONTINUE